2-Amino-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, 97.0%, 100g

2-Chloro-3,5-dibromotoluene, 95.0%, 25g

(4-((4-Chloro-3-(trifluoromethyl)phenyl)sulfonyl)piperazin-1-yl)(4-(5-methyl-1H-pyrazol-1-yl)phenyl)methanone, 99.0%, 250mg

3,4-Diaminobenzoic acid, 97.0%, 1kg

2-Chloro-3-nitro-6-phenylpyridine, 95.0%, 10g

2-((5-(3-(Benzhydrylamino)-3-oxopropyl)naphthalen-1-yl)oxy)acetic acid, 95+%, 250mg

4,4'-Thiobis(2-(tert-butyl)-5-methylphenol), 95.0%, 500g

Plan PLi 4x/0,10 objetivo IOS corregido al infinito. Distancia de trabajo 21,0 mm

2-(4-((2,4-Dioxothiazolidin-5-yl)methyl)phenoxy)acetic acid, 95.0%, 5g

CYCLOPROPANOL, 95.0%, 10g

1-(2-Bromoethoxy)-3-(trifluoromethyl)benzene, 98%, 500mg

5-bromo-3-methyl-2-(4H-1,2,4-triazol-4-yl)pyridine, 95.0%, 25g

9,9'-Di([1,1'-biphenyl]-4-yl)-9H,9'H-3,3'-bicarbazole>98.0%(HPLC)(T)1g